Modelling heterogeneity variances in multiple treatment comparison meta-analysis--are informative priors the better solution?
about
Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysisGetReal in network meta-analysis: a review of the methodology.Implementing informative priors for heterogeneity in meta-analysis using meta-regression and pseudo data.Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis.An investigation of the impact of using different methods for network meta-analysis: a protocol for an empirical evaluationA Microsoft-Excel-based tool for running and critically appraising network meta-analyses--an overview and application of NetMetaXLMethods for calculating confidence and credible intervals for the residual between-study variance in random effects meta-regression models.Assumptions of Mixed Treatment Comparisons in Health Technology Assessments - Challenges and Possible Steps for Practical Application.Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis.Reporting of results from network meta-analyses: methodological systematic review.Using indirect comparisons to compare interventions within a Cochrane review: a tool for comparative effectiveness research.Combining randomized and non-randomized evidence in clinical research: a review of methods and applications.Assessing key assumptions of network meta-analysis: a review of methods.Bayesian bivariate meta-analysis of diagnostic test studies with interpretable priors.SVR12 is higher than SVR24 in treatment-naïve hepatitis C genotype 1 patients treated with peginterferon plus ribavirin.A design-by-treatment interaction model for network meta-analysis with random inconsistency effects
P2860
Q28303682-F03D2D1B-EBFD-4FD8-935E-8A93422B364BQ30251972-0D144656-B20F-4385-BA1F-AB5F3115FE04Q31125687-73CB2ED8-6E56-4C7C-B812-ECE1C5860837Q33791885-15F20248-EAB8-446E-8F82-90A2225B09D3Q33831023-CE89F6FE-D821-49C3-9102-FE5C3082402DQ34330494-D49B30E7-D4A4-48E2-BE9F-AD2F2DDE2533Q35241792-D8B84F47-CE66-4EC1-B197-94F0819629E3Q36100127-B7420E63-EF15-405A-B9C0-04B5CB9C3268Q38133389-60EEEECC-272B-429D-A9C3-C91DF6ED2446Q38195122-69A4015B-98CE-4731-A0A4-4B03FB62FAABQ38256056-A6633261-96BE-4004-88F1-904A820BEC45Q38512940-370FD8B1-2C4E-4B77-9D4F-A8CB1AED661EQ38520487-13080D7B-2782-40AE-A88C-43CEC857B18CQ38802821-DBBA134D-3EE3-46B1-82C6-3E306D714894Q39261339-F43561F2-0CCF-4A21-9EFD-4EEAAC04BDD7Q42243147-233AE55E-8D6E-45A2-9908-D7BAABDFDBAD
P2860
Modelling heterogeneity variances in multiple treatment comparison meta-analysis--are informative priors the better solution?
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Modelling heterogeneity varian ...... ve priors the better solution?
@ast
Modelling heterogeneity varian ...... ve priors the better solution?
@en
Modelling heterogeneity varian ...... ve priors the better solution?
@nl
type
label
Modelling heterogeneity varian ...... ve priors the better solution?
@ast
Modelling heterogeneity varian ...... ve priors the better solution?
@en
Modelling heterogeneity varian ...... ve priors the better solution?
@nl
prefLabel
Modelling heterogeneity varian ...... ve priors the better solution?
@ast
Modelling heterogeneity varian ...... ve priors the better solution?
@en
Modelling heterogeneity varian ...... ve priors the better solution?
@nl
P2860
P356
P1476
Modelling heterogeneity varian ...... ve priors the better solution?
@en
P2093
Edward J Mills
Kristian Thorlund
P2860
P2888
P356
10.1186/1471-2288-13-2
P577
2013-01-11T00:00:00Z
P5875
P6179
1044605973